127 related articles for article (PubMed ID: 35694724)
21. Development and psychometric validation of a patient-reported outcome measure of recurrent urinary tract infection impact: the Recurrent UTI Impact Questionnaire.
Newlands AF; Roberts L; Maxwell K; Kramer M; Price JL; Finlay KA
Qual Life Res; 2023 Jun; 32(6):1745-1758. PubMed ID: 36740638
[TBL] [Abstract][Full Text] [Related]
22. Sialadenitis Without Sialolithiasis Treated by Sialendoscopy.
Pace CG; Hwang KG; Papadaki ME; Troulis MJ
J Oral Maxillofac Surg; 2015 Sep; 73(9):1748-52. PubMed ID: 25863231
[TBL] [Abstract][Full Text] [Related]
23. Quality of life after sialendoscopy: prospective non-randomized study.
Melo GM; Neves MC; Rosano M; Vanni CMRS; Abrahao M; Cervantes O
BMC Surg; 2022 Jan; 22(1):11. PubMed ID: 34998366
[TBL] [Abstract][Full Text] [Related]
24. Sialendoscopy With Intraductal Steroid Irrigation in Patients With Sialadenitis Without Sialoliths.
Lele SJ; Hamiter M; Fourrier TL; Nathan CA
Ear Nose Throat J; 2019 Jun; 98(5):291-294. PubMed ID: 31012349
[TBL] [Abstract][Full Text] [Related]
25. Pediatric sialendoscopy indications and outcomes.
Ogden MA; Rosbe KW; Chang JL
Curr Opin Otolaryngol Head Neck Surg; 2016 Dec; 24(6):529-535. PubMed ID: 27636984
[TBL] [Abstract][Full Text] [Related]
26. Allergy-Related Sialodochitis: A Preliminary Cohort Study.
Zhao YN; Zhang LQ; Zhang YQ; Chen Y; Liu DG; Yu GY
Laryngoscope; 2021 Sep; 131(9):2030-2035. PubMed ID: 33710620
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
Lipton RB; Gandhi P; Stokes J; Cala ML; Evans CJ; Knoble N; Gelhorn HL; Revicki D; Viswanathan HN; Dodick DW
Headache; 2022 Jan; 62(1):89-105. PubMed ID: 34962305
[TBL] [Abstract][Full Text] [Related]
28. How to measure experiences of healthcare quality in Denmark among patients with heart disease? The development and psychometric evaluation of a patient-reported instrument.
Zinckernagel L; Schneekloth N; Zwisler AO; Ersbøll AK; Rod MH; Jensen PD; Timm H; Holmberg T
BMJ Open; 2017 Oct; 7(10):e016234. PubMed ID: 29084787
[TBL] [Abstract][Full Text] [Related]
29. Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire.
La Touche R; Pardo-Montero J; Gil-Martínez A; Paris-Alemany A; Angulo-Díaz-Parreño S; Suárez-Falcón JC; Lara-Lara M; Fernández-Carnero J
Pain Physician; 2014; 17(1):95-108. PubMed ID: 24452650
[TBL] [Abstract][Full Text] [Related]
30. Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus.
Buchholzer S; Faure F; Tcheremissinoff L; Herrmann FR; Lombardi T; Ng SK; Lopez JM; Borner U; Witt RL; Irvine R; Abboud O; Cernea CR; Ghan S; Matsunobu T; Ahmad Z; Morton R; Anicin A; Magdy EA; Al Abri R; Konstantinidis I; Capaccio P; Klein H; Poorten VV; Lombardi D; Lyons B; Al Rand H; Liao G; Kim JK; Subha S; Su RY; Su CH; Boselie F; Andre R; Seebach JD; Marchal F
Laryngoscope; 2022 Feb; 132(2):322-331. PubMed ID: 34236085
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin for chronic parotid sialadenitis: A case series and systematic review.
Strohl MP; Chang CF; Ryan WR; Chang JL
Laryngoscope Investig Otolaryngol; 2021 Jun; 6(3):404-413. PubMed ID: 34195360
[TBL] [Abstract][Full Text] [Related]
32. Salivary, lacrimal and nasal (SALANS) measure to assess side effects following radioactive iodine treatment: development, psychometric properties, and factor structure.
Jonklaas J; Carr AL; Luta G; Yu C; Jensen RE; Reasner E; Winslow J; Kuo CC; Davidson BJ; Esposito G; Bloom G; Diamond-Rossi SA; Graves KD
Qual Life Res; 2024 Jul; 33(7):2011-2023. PubMed ID: 38769210
[TBL] [Abstract][Full Text] [Related]
33. Pediatric sialadenitis.
Francis CL; Larsen CG
Otolaryngol Clin North Am; 2014 Oct; 47(5):763-78. PubMed ID: 25128215
[TBL] [Abstract][Full Text] [Related]
34. Salivary endoscopy for idiopathic chronic sialadenitis.
Vashishta R; Gillespie MB
Laryngoscope; 2013 Dec; 123(12):3016-20. PubMed ID: 23712592
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic-assisted gland-preserving therapy for chronic sialadenitis: a German and US comparison.
Gillespie MB; Koch M; Iro H; Zenk J
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):903-8. PubMed ID: 21844406
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).
Hudgens S; Phillips-Beyer A; Newton L; Seboek Kinter D; Benes H
Patient; 2021 Mar; 14(2):249-268. PubMed ID: 33131027
[TBL] [Abstract][Full Text] [Related]
37. Clinical and quality-of-life outcomes following gland-preserving surgery for chronic sialadenitis.
Gillespie MB; O'Connell BP; Rawl JW; McLaughlin CW; Carroll WW; Nguyen SA
Laryngoscope; 2015 Jun; 125(6):1340-4. PubMed ID: 25424183
[TBL] [Abstract][Full Text] [Related]
38. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
[TBL] [Abstract][Full Text] [Related]
39. Patient experiences questionnaire for interdisciplinary treatment for substance dependence (PEQ-ITSD): reliability and validity following a national survey in Norway.
Haugum M; Iversen HH; Bjertnaes O; Lindahl AK
BMC Psychiatry; 2017 Feb; 17(1):73. PubMed ID: 28219361
[TBL] [Abstract][Full Text] [Related]
40. Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS.
Price N; Jackson SR; Avery K; Brookes ST; Abrams P
BJOG; 2006 Jun; 113(6):700-12. PubMed ID: 16709214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
